본문 바로가기
KERD
논문KCI 등재

Complementarity between 18F-FDG PET/CT and Ultrasonography or Angiography in Carotid Plaque Characterization

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background and Purpose To estimate clinical roles of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus angiography and ultrasonography in carotid plaque characterization. Methods We characterized two groups of patients with recently (<1 month) symptomatic (n=14;age=71.8±8.6 years, mean±SD) or chronic (n=13, age=68.9±9.0 years) carotid stenosis using a battery of imaging tests: diffusion magnetic resonance (MR) imaging, MR or transfemoral angiography, duplex ultrasonography (DUS), and carotid FDG-PET/computed tomography. Results The degree of angiographic stenosis was greater in patients with recently symptomatic carotid plaques (67.5±21.5%) than in patients with chronic carotid plaques (32.4±26.8%,p=0.001). Despite the significant difference in the degree of stenosis, lesional maximum standardized uptake values (maxSUVs) on the carotid FDG-PET did not differ between the recently symptomatic (1.56±0.53) and chronic (1.56±0.34, p=0.65) stenosis groups. However, lesional-tocontralesional maxSUV ratios were higher in the recently symptomatic stenosis group (113±17%) than in the chronic stenosis group (98±10%, p=0.017). The grayscale median value of the lesional DUS echodensities was lower in the recently symptomatic stenosis group (28.2±10.0, n=9) than in the chronic stenosis group (53.9±14.0, n=8; p=0.001). Overall, there were no significant correlations between angiographic stenosis, DUS echodensity, and FDG-PET maxSUV. Case/subgroup analyses suggested complementarity between imaging modalities. Conclusions There were both correspondences and discrepancies between the carotid FDG-PET images and DUS or angiography data. Further studies are required to determine whether FDGPET could improve the clinical management of carotid stenosis.

Abstract

Background and Purpose To estimate clinical roles of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus angiography and ultrasonography in carotid plaque characterization. Methods We characterized two groups of patients with recently (<1 month) symptomatic (n=14;age=71.8±8.6 years, mean±SD) or chronic (n=13, age=68.9±9.0 years) carotid stenosis using a battery of imaging tests: diffusion magnetic resonance (MR) imaging, MR or transfemoral angiography, duplex ultrasonography (DUS), and carotid FDG-PET/computed tomography. Results The degree of angiographic stenosis was greater in patients with recently symptomatic carotid plaques (67.5±21.5%) than in patients with chronic carotid plaques (32.4±26.8%,p=0.001). Despite the significant difference in the degree of stenosis, lesional maximum standardized uptake values (maxSUVs) on the carotid FDG-PET did not differ between the recently symptomatic (1.56±0.53) and chronic (1.56±0.34, p=0.65) stenosis groups. However, lesional-tocontralesional maxSUV ratios were higher in the recently symptomatic stenosis group (113±17%) than in the chronic stenosis group (98±10%, p=0.017). The grayscale median value of the lesional DUS echodensities was lower in the recently symptomatic stenosis group (28.2±10.0, n=9) than in the chronic stenosis group (53.9±14.0, n=8; p=0.001). Overall, there were no significant correlations between angiographic stenosis, DUS echodensity, and FDG-PET maxSUV. Case/subgroup analyses suggested complementarity between imaging modalities. Conclusions There were both correspondences and discrepancies between the carotid FDG-PET images and DUS or angiography data. Further studies are required to determine whether FDGPET could improve the clinical management of carotid stenosis.

참고문헌 (42)

  1. Writing Group Members, "Heart disease and stroke statistics--2010 update: a report from the American Heart Association", Circulation, 121, pp.e46~e215 (2010)
  2. Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
  3. Hermus L, "Advanced carotid plaque imaging", European Journal of Vascular and Endovascular Surgery, 39, pp.125~133 (2010)
  4. Li ZY, "Assessment of carotid plaque vulnerability using structural and geometrical determinants", Circulation Journal, 72, pp.1092~1099 (2008)
  5. 이동근, "Will Molecular Optical Imaging Have Clinically Important Roles in Stroke Management, and How?", Journal of Clinical Neurology, 6(1), pp.10~18 (2010), 대한신경과학회
  6. Kolodgie FD, "Pathology of atherosclerosis and stenting", Neuroimaging Clinics of North America, 17, pp.285~301 (2007)
  7. Libby P, "Stabilization of atherosclerotic plaques: new mechanisms and clinical targets", Nature Medicine, 8, pp.1257~1262 (2002)
  8. Tahara N, "Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis", Journal of Nuclear Medicine, 50, pp.331~334 (2009)
  9. Waki H, "Ultrasonic tissue characterization of the atherosclerotic carotid artery: histological correlates or carotid integrated backscatter", Circulation Journal, 67, pp.1013~1016 (2003)
  10. Aikawa M, "Cardiovascular inflammation", International Journal of Inflammation, 2012, pp.904608~ (2012)
  11. Morishige K, "High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis", Circulation, 122, pp.1707~1715 (2010)
  12. Libby P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2002)
  13. Deguchi JO, "Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo", Circulation, 114, pp.55~62 (2006)
  14. Sheikine Y, "FDG-PET imaging of atherosclerosis: do we know what we see?", Atherosclerosis, 211, pp.371~380 (2010)
  15. Davies JR, "FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis", The International Journal of Cardiovascular Imaging, 26, pp.41~48 (2010)
  16. -fluorodeoxyglucose positron emission tomography, "Circulation", 2002, 2708~2711
  17. Marnane M, "Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence", Annals of Neurology, 71, pp.709~718 (2012)
  18. Ben-Haim S, "Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET", CT studies, 2006, pp.13, 791~800
  19. Spagnoli LG, "Role of inflammation in atherosclerosis", Journal of Nuclear Medicine, 48, pp.1800~1815 (2007)
  20. Menezes LJ, "What is the natural history of 18F-FDG uptake in arterial atheroma on PET", CT? Implications for imaging the vulnerable plaque, 2010, pp.211, 136~140
  21. Laurberg JM, "Imaging of vulnerable atherosclerotic plaques with FDGmicroPET: no FDG accumulation", Atherosclerosis, 192, pp.275~282 (2007)
  22. Okane K, "18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries", European Journal of Nuclear Medicine and Molecular Imaging, 33, pp.589~594 (2006)
  23. Davies JR, "Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging", Stroke, 36, pp.2642~2647 (2005)
  24. Kim DE, "Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging", Arteriosclerosis, Thrombosis, and Vascular Biology, 30, pp.449~456 (2010)
  25. Sitzer M, "Internal carotid artery angle of origin: a novel risk factor for early carotid atherosclerosis", Stroke, 34, pp.950~955 (2003)
  26. "North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress", Stroke, 22, pp.711~720 (1991)
  27. Ferguson GG, "The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients", Stroke, 30, pp.1751~1758 (1999)
  28. Rudd JH, "(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials", Journal of the American College of Cardiology, 50, pp.892~896 (2007)
  29. Rudd JH, "Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations", Journal of Nuclear Medicine, 49, pp.871~878 (2008)
  30. AbuRahma AF, "Carotid plaque ultrasonic heterogeneity and severity of stenosis", Stroke, 33, pp.1772~1775 (2002)
  31. Spagnoli LG, "Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke", JAMA, 292, pp.1845~1852 (2004)
  32. Graebe M, "18FDG PET and ultrasound echolucency in carotid artery plaques", JACC: Cardiovascular Imaging, 3, pp.289~295 (2010)
  33. -FDG-PET, "CT", Annals of Nuclear Medicine, 23, pp.59~64 (2009)
  34. Tahara N, "The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography", European Heart Journal, 28, pp.2243~2248 (2007)
  35. van der Wal AC, "Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability", Cardiovascular Research, 41, pp.334~344 (1999)
  36. van Gils MJ, "Evolution of atherosclerotic carotid plaque morphology: do ulcerated plaques heal? A serial multidetector CT angiography study", Cerebrovascular Diseases, 31, pp.263~270 (2011)
  37. Cohade C, "“USA-Fat”: prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET", CT, 2003, pp.44, 1267~1270
  38. Zhou SM, "Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation", Medical Physics, 31, pp.2577~2583 (2004)
  39. Kwee RM, "Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging", Stroke, 40, pp.3718~3724 (2009)
  40. Bassiouny HS, "Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques", Journal of Vascular Surgery, 9, pp.202~212 (1989)
  41. Rothwell PM, "Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists’ Collaborative Group", Stroke, 31, pp.615~621 (2000)
  42. Prabhakaran S, "Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study", Stroke, 37, pp.2696~2701 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (9건)